Search - tctmd.com

Displaying 401 - 420 of 738

Sort: Relevancy | Date

News Daily News

CV Prevention Meds Underused in Hispanic, Latinx PAD Patients

L.A. McKeown

August 12, 2020

News Daily News

ADHD Drug Overprescribing Raises Concerns Over Future CV Events

L.A. McKeown

August 11, 2020

News Daily News

High-Sensitivity Troponin Hones ASCVD Risk in Secondary Prevention

Michael O'Riordan

August 11, 2020

News Daily News

Analysis Supports Short DAPT Followed by P2Y12 Inhibitor Monotherapy After DES PCI

L.A. McKeown

August 10, 2020

News Conference News SCCT 2020

ISCHEMIA, Patient Age in PROMISE Among Top CT Papers of the Year at SCCT

Yael L. Maxwell

July 20, 2020

News Daily News

Less MI, CV Death With Noninvasive Testing for Chest Pain: Observational Data

Michael O'Riordan

July 14, 2020

News Daily News

Smoking Still Common, Tied to Higher Mortality in Young MI Patients

Yael L. Maxwell

July 09, 2020

News Daily News

Inflammation Plays Into the ASCVD Risk Associated With Lp(a): ACCELERATE

Michael O'Riordan

July 08, 2020

A secondary analysis from ASPREE sets up two large RCTs testing statins in an elderly primary-prevention population.

News Daily News

Statins Cut CV Risk but Don’t Boost Disability-Free Survival in Healthy Elderly

Michael O'Riordan

July 06, 2020

News Daily News

Rivaroxaban May Yet Protect After a Hospital Stay: MARINER

Caitlin E. Cox

June 25, 2020

News Daily News

Rural-Urban Gap Widens for Cardiometabolic Health Disparities

Michael O'Riordan

June 22, 2020

News Daily News

Women, Elderly, Minorities Vastly Underrepresented in Clinical Trials Over Decades

Yael L. Maxwell

May 28, 2020

News Daily News

Coronary Calcium-Guided Statin Strategy Cost-effective in African-Americans

Michael O'Riordan

May 15, 2020

News Daily News

RV Strain a Prognostic Marker for Mortality in COVID-19

Caitlin E. Cox

May 04, 2020

News Daily News

Different Markers of Dyslipidemia Could Help Fine-tune CVD Prevention

Yael L. Maxwell

April 28, 2020

News Features

Hopes High for Anti-inflammatories to Combat COVID-19 Immune System Storms

Caitlin E. Cox

April 23, 2020

News Daily News

Smoker’s Paradox Debunked: Post-STEMI Outcomes Worse in Cigarette Smokers

Michael O'Riordan

April 15, 2020

News Conference News ACC 2020

Icosapent Ethyl’s CV Benefit Closely Tied to Serum EPA Levels: REDUCE-IT

Todd Neale

April 02, 2020

News Conference News ACC 2020

Pooled Inclisiran Data: Safe LDL-Lowering, Plus Hints of Fewer CVD Events

Michael O'Riordan

April 02, 2020

Hope for these hard-to-treat patients: more than half saw ≥ 50% decrease at 24 weeks, regardless of LDL receptor function.

News Conference News ACC 2020

Evinacumab Cuts LDL Cholesterol in Homozygous FH

Yael L. Maxwell

April 01, 2020

Advertisement

CV Prevention Meds Underused in Hispanic, Latinx PAD Patients

ADHD Drug Overprescribing Raises Concerns Over Future CV Events

High-Sensitivity Troponin Hones ASCVD Risk in Secondary Prevention

Analysis Supports Short DAPT Followed by P2Y12 Inhibitor Monotherapy After DES PCI

ISCHEMIA, Patient Age in PROMISE Among Top CT Papers of the Year at SCCT

Less MI, CV Death With Noninvasive Testing for Chest Pain: Observational Data

Smoking Still Common, Tied to Higher Mortality in Young MI Patients

Inflammation Plays Into the ASCVD Risk Associated With Lp(a): ACCELERATE

Statins Cut CV Risk but Don’t Boost Disability-Free Survival in Healthy Elderly

Rivaroxaban May Yet Protect After a Hospital Stay: MARINER

Rural-Urban Gap Widens for Cardiometabolic Health Disparities

Women, Elderly, Minorities Vastly Underrepresented in Clinical Trials Over Decades

Coronary Calcium-Guided Statin Strategy Cost-effective in African-Americans

RV Strain a Prognostic Marker for Mortality in COVID-19

Different Markers of Dyslipidemia Could Help Fine-tune CVD Prevention

Hopes High for Anti-inflammatories to Combat COVID-19 Immune System Storms

Smoker’s Paradox Debunked: Post-STEMI Outcomes Worse in Cigarette Smokers

Icosapent Ethyl’s CV Benefit Closely Tied to Serum EPA Levels: REDUCE-IT

Pooled Inclisiran Data: Safe LDL-Lowering, Plus Hints of Fewer CVD Events

Evinacumab Cuts LDL Cholesterol in Homozygous FH

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content